Chapter 11: Henoch-Schönlein purpura nephritis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Schönlein purpura nephritis: A meta-analysis.International urology and nephrology · 2019
   Pooled it
2. Efficacy and safety of telitacicept in children with IgA vasculitis and IgA vasculitis nephritis: a single-center retrospective study.Pediatric rheumatology online journal · 2025
   Observational
3. Long-term Results in Children with Henoch-Schönlein Nephritis.Medeniyet medical journal · 2022
   Article
4. Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement.Clinical rheumatology · 2022
   Article
5. Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis.Frontiers in pharmacology · 2022
   Review
6. Rapidly progressive IgA vasculitis-associated nephritis successfully treated with immunosuppressive therapy in an adolescent with chronic granulomatous disease.CEN case reports · 2021
   Article
7. IgA vasculitis.Seminars in immunopathology · 2021
   Review
8. Leflunomide therapy for IgA vasculitis with nephritis in children.BMC pediatrics · 2021
   Article
9. Management of IgA Vasculitis with Nephritis.Paediatric drugs · 2021
   Review
10. IgA Nephropathy: An Interesting Autoimmune Kidney Disease.The American journal of the medical sciences · 2021
    Review
11. Atypical Bacterial Pathogens and Small-Vessel Leukocytoclastic Vasculitis of the Skin in Children: Systematic Literature Review.Pathogens (Basel, Switzerland) · 2021
    Review
12. Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis.Therapeutic advances in musculoskeletal disease · 2021
    Review
13. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.BMC pediatrics · 2020
    Article
14. Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.Pediatric nephrology (Berlin, Germany) · 2020
    Article
15. Safety and Efficacy Evaluation of Traditional Chinese Medicine (Qingre-Lishi-Yishen Formula) Based on Treatment of Regular Glucocorticoid Combined with Cyclophosphamide Pulse in Children Suffered from Moderately Severe Henoch-Schonlein Purpura Nephritis with Nephrotic Proteinuria.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
16. Global Glomerulosclerosis and Segmental Glomerulosclerosis Could Serve as Effective Markers for Prognosis and Treatment of IgA Vasculitis With Nephritis.Frontiers in medicine · 2020
    Article
17. Determination of Risk Factors in Children Diagnosed With Henoch-Schönlein Purpura.Archives of rheumatology · 2018
    Article
18. Significance of histological crescent formation in patients with IgA vasculitis (Henoch-Schönlein purpura)-related nephritis: a cohort in the adult Chinese population.BMC nephrology · 2018
    Article
19. Successful Treatment of IgA Vasculitis Complicated with Bowel Perforation and Crescentic Glomerulonephritis by Combination Therapy of Glucocorticoid, Cyclosporine and Factor XIII Replacement.Internal medicine (Tokyo, Japan) · 2018
    Article
20. Renal Prognosis and Related Risk Factors for Henoch-Schönlein Purpura Nephritis: A Chinese Adult Patient Cohort.Scientific reports · 2018
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.